Clinical Trials · NCT07836140

A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.

CompletedPhase 2Semaglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Second Affiliated Hospital of Soochow University
Enrollment
60
Start date
Apr 2024
Locations
1 site, China
Primary endpoint
HOMA2-β index
View Semaglutide compound reference